Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Managing Equipment Breakdowns in Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Managing Equipment Breakdowns in Manufacturing – V 2.0

Standard Operating Procedure for Managing Equipment Breakdowns in Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/136/2025
Supersedes SOP/SIM/136/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define the procedure for immediate and effective handling of equipment breakdowns in sterile injectable manufacturing. This SOP ensures timely communication, risk mitigation, documentation, and restoration of operations with minimal impact on product quality and compliance.

2. Scope

This SOP applies to all sterile manufacturing

equipment including filling lines, lyophilizers, autoclaves, laminar airflow units, solution preparation tanks, and other supporting machinery used within the production area.

3. Responsibilities

  • Machine Operator: Identify and report any equipment malfunction immediately.
  • Maintenance Technician: Investigate and resolve breakdowns and perform repairs as per protocol.
  • Production Supervisor: Coordinate communication between departments, assess product risk, and approve restart.
  • QA Officer: Review impact on product quality and provide disposition or hold instructions.
See also  Sterile Injectable Manufacturing: SOP for Sterilization of Manufacturing Equipment - V 2.0

4. Accountability

The Head of Production is accountable for ensuring that equipment breakdowns are documented, addressed, and closed in accordance with this SOP and GMP requirements.

5. Procedure

5.1 Immediate Action Upon Breakdown

  1. Stop the affected process immediately to prevent further damage or product compromise.
  2. Switch on warning indicators or signage for breakdown notification.
  3. Inform the Production Supervisor and Engineering/Maintenance Department.
  4. Record the breakdown event in the Equipment Breakdown Logbook (Annexure-1).

5.2 Assessment and Risk Evaluation

  1. Maintenance team conducts a preliminary diagnosis of the failure cause.
  2. Production and QA jointly evaluate:
    • Any impact on in-process material/product
    • Duration of stoppage
    • Cleanroom hold-time limits or exposure
  3. If product is affected, move batch to quarantine and initiate deviation report.

5.3 Repair and Restoration

  1. Maintenance performs repair as per standard equipment manual or internal protocol.
  2. Use calibrated tools and ensure all repairs are documented in Annexure-2: Maintenance Activity Sheet.
  3. Ensure all replacement parts are compliant and traceable.

5.4 Post-Repair Validation and Restart

  1. Verify proper functioning through dry run (no product).
  2. QA to inspect equipment and approve for restart after evaluating cleaning, validation (if required), and impact analysis.
  3. Record restart time in Equipment Breakdown Logbook.
See also  Sterile Injectable Manufacturing: SOP for Segregating Finished Injectable Products by Batch - V 2.0

5.5 Cleaning Requirements

  1. Clean the equipment per applicable SOP before restarting the process.
  2. If equipment was open to environment for extended periods, perform additional microbial and particulate monitoring before use.

5.6 Documentation and Reporting

  1. Complete all entries in Equipment Breakdown Logbook (Annexure-1).
  2. Prepare Deviation Report if applicable (Annexure-3).
  3. All maintenance tasks must be recorded in Annexure-2.

5.7 Escalation and Communication

  1. If repair exceeds 2 hours or multiple departments are impacted, escalate to Engineering Head and QA Head.
  2. Communicate delays to Production Planning Team.

5.8 Preventive Actions

  1. Analyze breakdown trends monthly.
  2. Identify and plan preventive maintenance schedules accordingly.
  3. Revise SOPs if repeated failure modes are identified.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Equipment Breakdown Logbook – Annexure-1
  2. Maintenance Activity Sheet – Annexure-2
  3. Deviation Report – Annexure-3

8. References

  • WHO GMP Guidelines – Equipment Management
  • ICH Q9 – Quality Risk Management
  • 21 CFR Part 211 – Subpart D: Equipment
See also  Packaging: SOP for Visual Inspection of Packed Injectable Products - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Equipment Breakdown Logbook

Date Equipment Batch No. Breakdown Time Restart Time Initial Reported By Remarks
20/06/2025 Vial Filler INJ/045/2025 10:45 AM 01:30 PM Rajesh Kumar Seal actuator fault

Annexure-2: Maintenance Activity Sheet

Date Equipment Description of Work Parts Replaced Performed By Verified By
20/06/2025 Vial Filler Actuator alignment Actuator Cylinder Sunil Patil QA Officer

Annexure-3: Deviation Report

Deviation No. DEV-136-2025-01
Date 20/06/2025
Equipment Vial Filler
Description Mid-batch breakdown caused hold-time exceedance
Corrective Action Replaced faulty part, revalidated
Preventive Action Inspection checklist revised

Revision History

Revision Date Revision No. Details Reason Approved By
01/07/2022 1.0 Initial SOP release New Equipment SOP QA Head
24/06/2025 2.0 Added escalation steps and Annexure templates Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Incorporating ALCOA+ Principles into SOP Development for Data Integrity
Next Post: Gel Manufacturing: SOP for Environmental Monitoring Program in Gel Manufacturing Area – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version